Adding low dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia : results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients

収録刊行物

• Br J Haematol.

  Br J Haematol. 138 186-195, 2007